Trials / Completed
CompletedNCT00958880
Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
Placebo-Controlled Evaluation of the Efficacy of Yohimbine Hydrochloride for Enhancing the Effects of CBT for Social Phobia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Southern Methodist University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the utility of Yohimbine hydrochloride for facilitating fear extinction in a sample of patients with social phobia who will be treated with CBT.
Detailed description
The primary aim is to determine the relative efficacy of exposure-based CBT for social phobia when conducted with adjunctive acute (prior to four of five sessions) administration of either Yohimbine hydrochloride (10.8 mg) or placebo during core exposure sessions. Based on the available evidence, the investigators hypothesize that acute treatment with Yohimbine hydrochloride prior to exposure-based CBT would facilitate the extinction of fear that occurs with this treatment and would enhance treatment outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Group Cognitive Behavioral Therapy | 5 weeks of group CBT for Social Anxiety. The aim of CBT is to help participants become more comfortable with social situations One arm will receive placebo augmented Group Cognitive Behavioral Therapy and the other will receive yohimbine hydrochloride augmented cognitive behavioral therapy. |
| DRUG | Yohimbine Hydrochloride | Participants in the Yohimbine augmented arm will receive 4 doses of Yohimbine Hydrochloride before 4 of the 5 group cognitive behavioral therapy sessions. |
| DRUG | Sugar Pill | Participants in the placebo (sugar pill) augmented arm will receive 4 doses of a sugar pill before 4 of the 5 group cognitive behavioral therapy sessions. |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2009-08-13
- Last updated
- 2013-11-11
- Results posted
- 2013-11-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00958880. Inclusion in this directory is not an endorsement.